Zacks Investment Research on MSN20 小时
JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer
J&J JNJ recently reported new positive data from the phase III MARIPOSA study, which compared the combination of Rybrevant and Lazcluze against AstraZeneca’s AZN Tagrisso in first-line EGFR-mutated ...
来自MSN5 个月
Blue Origin constructs new New Shepard rocket-capsule combo to expand human launches
A replacement booster along with a new crew-capable capsule is set to debut as early as Monday. Slated to fly on the NS-27 mission, the new booster topped with the capsule named the RSS Kármán ...